检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

In-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib Therapy in Newly Diagnosed Multiple Myeloma (NDMM) Patients from the Community-Based US MM-6 Study: Subgroup Analyses of the Fully Accrued Dataset in Patients Aged <75 and ≥75 Years

Ruemu E. Birhiray,Robert M. Rifkin,Christopher A. Yasenchak,January Fields-Meehan,Roger M. Lyons, Ramalingham Ratnasabapathy,Kimberly Bogard,Kim Tran,Dasha Cherepanov,Stephen J. Noga,Saulius K. Girnius,Stephen J. Noga

Blood（2022）

引用 0|浏览13
暂无评分
关键词
multiple myeloma,oral ixazomib therapy,parenteral bortezomib,community-based
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要